PulseAugur
实时 23:26:29
English(EN) AstraZeneca said to have explored Bristol Myers merger

AstraZeneca 传洽谈收购 Bristol Myers Squibb

据报道,AstraZeneca 已在初步讨论中探索了收购 Bristol Myers Squibb 的可能性。此次合并将创建一个在美国市场拥有重要影响力的制药巨头。Bristol Myers Squibb 目前正面临 EliquisOpdivo 等关键药物的专利到期,同时也从新疗法中获得增长。 AI

排序理由 该集群讨论了两大制药公司之间潜在的巨头合并,属于重要的行业动态。[lever_c_demoted from significant: ic=1 ai=0.0]

在 Fortune 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →

AstraZeneca 传洽谈收购 Bristol Myers Squibb

报道来源 [1]

  1. Fortune TIER_1 English(EN) · Dinesh Nair, Michelle F. Davis, Ashleigh Furlong, Kelly Gilblom, Bloomberg ·

    AstraZeneca said to have explored Bristol Myers merger

    Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.